“With existing chemistries under threat of resistance, Verpixo will redefine custom fungicide programs to sustain healthier crops, better yields and greater value,” Mr Koch said.
Mr Hoyle said the trial data spoke for itself.
“Seeing the results of the trial and increase in marketable yield was fantastic,” he said.
“Trials are always exciting. They give us as farmers a feel for the product’s capabilities firsthand and an opportunity to see how it’s going to fit into our farming system,” Mr Hoyle said.
“At the end of the day that’s what we’re all about, trying to produce quality food and reduce waste.”
Along with the results from Ashbern Farms, another trial in Wamuran showcased Verpixo’s strength in managing key diseases in strawberries, highlighting its suitability as a core solution for growers and their resistant management needs.
Corteva Agriscience Field Scientist, Greg Wells said the results of the trial underscored Verpixo’s efficacy in disease management.
“For the strawberry trial in Wamuran, we conducted a season-long sequence of treatments,” Mr Wells said.
“A sequence of sixteen treatments were placed on the strawberries, with Verpixo sprayed once or twice in a row to test its control on botrytis and other key diseases.
“The trial indicated Verpixo had excellent disease control at low use rates, resulting in greater yield potential and a reduction in disease incidence.”
Verpixo Adavelt active is registered by the Australian Pesticides and Veterinary Medicines Authority (APVMA) for use in strawberries, fruiting vegetables, leafy vegetables and cucurbits.
“We are committed to helping growers navigate the complexity of plant disease and mitigate the effects of emerging or established resistance,” Mr Koch said.
“Verpixo Adavelt active is designed to meet these needs and offers a cornerstone upon which disease management programs can continue to be strengthened.”
